Kamini Nirmala Mendis
#62,105
Most Influential Person Now
Sri Lankan malaria researcher
Kamini Nirmala Mendis's AcademicInfluence.com Rankings
Kamini Nirmala Mendisbiology Degrees
Biology
#9034
World Rank
#12191
Historical Rank
Parasitology
#47
World Rank
#55
Historical Rank
Molecular Biology
#2514
World Rank
#2554
Historical Rank
Download Badge
Biology
Kamini Nirmala Mendis's Degrees
- Bachelors Biological Sciences University of Colombo
- Masters Molecular Biology University Grants Commission
- PhD Medical Parasitology University Grants Commission
Why Is Kamini Nirmala Mendis Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kamini Nirmala Mendis is a Sri Lankan professor emeritus at the University of Colombo and former malaria expert at the World Health Organization . Education Mendis went to Visakha Vidyalaya school in Colombo. She went to the University of Ceylon to study medicine in 1972, and then moved to the University of London in the UK for her PhD in 1980. For her M.D. in Microbiology, to complete her medical training, Mendis returned to her alma mater in 1989, now split into the University of Colombo.
Kamini Nirmala Mendis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The neglected burden of Plasmodium vivax malaria. (2001) (1061)
- Evolutionary and Historical Aspects of the Burden of Malaria (2002) (660)
- A Research Agenda to Underpin Malaria Eradication (2011) (659)
- Spatial targeting of interventions against malaria. (2000) (441)
- Global Epidemiology of Plasmodium vivax (2016) (292)
- From malaria control to eradication: The WHO perspective (2009) (290)
- Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. (1992) (250)
- A Research Agenda for Malaria Eradication: Vaccines (2011) (248)
- A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies. (2007) (185)
- Clustering of malaria infections within an endemic population: risk of malaria associated with the type of housing construction. (1991) (177)
- Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential (1991) (163)
- Rosetting: a new cytoadherence property of malaria-infected erythrocytes. (1988) (156)
- Malaria transmission-blocking vaccines—how can their development be supported? (2000) (146)
- The impact of repeated malaria attacks on the school performance of children. (2003) (142)
- Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. (1993) (132)
- Antigenic variation of cloned Plasmodium fragile in its natural host Macaca sinica. Sequential appearance of successive variant antigenic types (1987) (126)
- Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans (1987) (125)
- Transfection of the malaria parasite and expression of firefly luciferase. (1993) (117)
- Malaria risk factors in an endemic region of Sri Lanka, and the impact and cost implications of risk factor-based interventions. (1998) (112)
- Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms (1994) (112)
- A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children. (2006) (104)
- Baculovirus Merozoite Surface Protein 1 C-Terminal Recombinant Antigens Are Highly Protective in a Natural Primate Model for HumanPlasmodium vivax Malaria (1998) (102)
- ABO-blood-group types and protection against severe, Plasmodium falciparum malaria (2005) (100)
- Uninfected erythrocytes form "rosettes" around Plasmodium falciparum infected erythrocytes. (1989) (94)
- Characteristics of malaria transmission in Kataragama, Sri Lanka: a focus for immuno-epidemiological studies. (1990) (92)
- Tumour necrosis factor‐dependent parasite‐killing effects during paroxysms in non‐immune Plasmodium vivax malaria patients (1992) (89)
- Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria. (1988) (86)
- TNFα*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans (1999) (85)
- Immunity to sexual stages of malaria parasites. (1988) (84)
- Plasmodium vivax in the Era of the Shrinking P. falciparum Map (2020) (82)
- Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. (1996) (81)
- Malaria mortality rates in South Asia and in Africa: implications for malaria control. (1998) (79)
- Clinical disease and pathogenesis in malaria. (1995) (77)
- The paroxysm of Plasmodium vivax malaria. (2003) (70)
- The ParaSight-F dipstick test as a routine diagnostic tool for malaria in Sri Lanka. (1997) (66)
- Maternal inheritance of extrachromosomal DNA in malaria parasites. (1994) (62)
- Boosting of transmission-blocking immunity during natural Plasmodium vivax infections in humans depends upon frequent reinfection (1988) (61)
- Conquering Malaria (2006) (61)
- Plasmodium vivax:recombination between potential allelic types of the merozoite surface protein MSP1 in parasites isolated from patients. (1993) (60)
- Cognitive performance at school entry of children living in malaria-endemic areas of Sri Lanka. (2003) (57)
- Quantifying genetic and nongenetic contributions to malarial infection in a Sri Lankan population. (2000) (57)
- Plasmodium falciparum malaria transmission‐blocking immunity under conditions of low endemicity as in Sri Lanka (1994) (56)
- Demonstration of anti-disease immunity to Plasmodium vivax malaria in Sri Lanka using a quantitative method to assess clinical disease. (1998) (54)
- Infectious reservoir of Plasmodium vivax and Plasmodium falciparum malaria in an endemic region of Sri Lanka. (1991) (53)
- Infectivity of Plasmodium vivax and P. falciparum to Anopheles tessellatus; relationship between oocyst and sporozoite development. (1993) (49)
- Patterns of acquired anti-malarial immunity in Sri Lanka. (1994) (47)
- Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014) (2015) (46)
- Implications of Plasmodium vivax Biology for Control, Elimination, and Research (2016) (46)
- Enterobius vermicularis in ectopic sites. (1977) (44)
- Antigenic polymorphism in malaria: is it an important mechanism for immune evasion? (1991) (43)
- Plasmodium vivax merozoite surface protein 1 C-terminal recombinant proteins in baculovirus. (1994) (43)
- Plasmodium vivax: isolation of mature asexual stages and gametocytes from infected human blood by colloidal silica (Percoll) gradient centrifugation. (1987) (42)
- Anti-parasite effects of cytokines in malaria. (1990) (41)
- Plasmodium cynomolgi: serum-mediated blocking and enhancement of infectivity to mosquitoes during infections in the natural host, Macaca sinica. (1990) (41)
- Characterization of imported malaria, the largest threat to sustained malaria elimination from Sri Lanka (2015) (41)
- Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting (2013) (39)
- Demonstration of antigenic polymorphism in Plasmodium vivax malaria with a panel of 30 monoclonal antibodies (1987) (37)
- Association of high plasma TNF-alpha levels and TNF-alpha/IL-10 ratios with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka (2013) (35)
- Human T cell proliferative responses to Plasmodium vivax antigens: evidence ofimmunosuppression following prolonged exposure to endemic malaria (1990) (35)
- Malaria elimination in Sri Lanka: what it would take to reach the goal (2014) (34)
- Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines. (1990) (33)
- Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector (1995) (32)
- The first introduced malaria case reported from Sri Lanka after elimination: implications for preventing the re-introduction of malaria in recently eliminated countries (2019) (31)
- Roll back malaria is unarguably both necessary and possible. (2000) (31)
- Technical and operational underpinnings of malaria elimination from Sri Lanka (2019) (30)
- Plasmodium vivax: cloning and expression of a major blood-stage surface antigen. (1988) (30)
- Modulation of human malaria transmission by anti-gamete transmission blocking immunity. (1988) (29)
- Evolutionary and Historical Aspects of the Burden of Malaria (2003) (28)
- Genetic complexity of Plasmodium vivax parasites in individual human infections analyzed with monoclonal antibodies against variant epitopes on a single parasite protein. (1990) (28)
- Immunoelectron microscopy of Schüffner's dots in Plasmodium vivax-infected human erythrocytes. (1988) (28)
- Transient Increase in Circulating y / 8 T Cells during Plasmodium vivax Malarial Paroxysms (2003) (27)
- Cutaneous leishmaniasis in Sri Lanka. An imported disease linked to the Middle East and African employment boom. (1990) (27)
- Characterization of C-terminal merozoite surface protein-1 baculovirus recombinant proteins from Plasmodium vivax and Plasmodium cynomolgi as recognized by the natural anti-parasite immune response. (1997) (26)
- Serological relationship of tumor necrosis factor-inducing exoantigens of Plasmodium falciparum and Plasmodium vivax (1992) (26)
- Target antigens of transmission blocking immunity of Plasmodium vivax malaria. Characterization and polymorphism in natural parasite isolates. (1990) (26)
- Diversity of Plasmodium vivax-induced antigens on the surface of infected human erythrocytes. (1988) (25)
- Transmission immunity in malaria: reflections on the underlying immune mechanisms during natural infections and following artificial immunization. (1992) (24)
- Congenital malaria due to Plasmodium vivax: a case report from Sri Lanka. (1982) (24)
- A mathematical model for Plasmodium vivax malaria transmission: estimation of the impact of transmission-blocking immunity in an endemic area. (1991) (24)
- A metropolitan hospital in a non-endemic area provides a sampling pool for epidemiological studies on vivax malaria in Sri Lanka. (1987) (24)
- Plasmodium vivax: karyotype polymorphism of field isolates. (1988) (23)
- Immunity to malarial antigens on the surface of Plasmodium falciparum-infected erythrocytes. (1983) (23)
- Malaria Terminology (1953) (23)
- A new polymorphic marker for PCR typing of Plasmodium vivax parasites. (1995) (22)
- Improved access to early diagnosis and complete treatment of malaria in Odisha, India (2019) (18)
- Method to estimate relative transmission efficiencies of Anopheles species (Diptera: Culicidae) in human malaria transmission. (1992) (17)
- The role of cytokines in Plasmodium vivax malaria. (1992) (16)
- Transmission blocking immunity may provide clues that antimalarial immunity is largely T-independent. (1991) (16)
- Anti‐circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka (1992) (16)
- Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria. (1990) (16)
- Use of synthetic peptides in the study of the antibody response to Plasmodium vivax sporozoites. (1990) (15)
- Plasmodium vivax: paroxysm-associated lipids mediate leukocyte aggregation (2007) (14)
- Vaccination to prevent transmission of Plasmodium yoelii malaria (1982) (14)
- Immunization to produce a transmission-blocking immunity in Plasmodium yoelii malaria infections. (1981) (13)
- Filarial infection of the breast. (1978) (13)
- HLA effects in malaria: increased parasite-killing immunity or reduced immunopathology? (1992) (13)
- Plasmodium vivax malaria: parasite biology defines potential targets for vaccine development (1988) (12)
- Trends in malaria research in 11 Asian Pacific countries: an analysis of peer-reviewed publications over two decades (2011) (11)
- Measuring malaria. (2006) (11)
- Preventing the re-establishment of malaria in Sri Lanka amidst the COVID-19 pandemic (2020) (11)
- Role of medicines in malaria control and elimination (2010) (10)
- Priorities in research and development of vaccines against Plasmodium vivax malaria. (2009) (10)
- Response of imported malaria patients to antimalarial medicines in Sri Lanka following malaria elimination (2017) (9)
- An indigenous case of Plasmodium ovale infection in Sri Lanka. (2008) (9)
- Sulphadoxine-pyrimethamine and chloroquine resistant Plasmodium falciparum infection in Sri Lanka. (1994) (9)
- Mass drug administration should be implemented as a tool to accelerate elimination: against (2019) (9)
- Biology and Decsriptions of the Larva and Pupa of Anopheles (Cellia) elegans James (1903) (1983) (8)
- Eliminating malaria should not be the end of vigilance (2019) (8)
- Regulatory action needed to stop the sale of oral artemisinin-based monotherapy. (2010) (8)
- Mediators and Mechanisms Associated with Paroxysm in Plasmodium vivax Malaria (1997) (6)
- Comprehensive case management of malaria: Operational research informing policy (2019) (6)
- Spatial technology & malaria control. (2009) (6)
- Monitoring of drug-resistant malaria in Africa (2002) (6)
- A comparative analysis of the outcome of malaria case surveillance strategies in Sri Lanka in the prevention of re‐establishment phase (2020) (6)
- Mass radical treatment of a group of foreign workers to mitigate the risk of re-establishment of malaria in Sri Lanka (2020) (5)
- Role of a dedicated support group in retaining malaria-free status of Sri Lanka (2019) (5)
- Monitoring of drug-resistant malaria in Africa [letter] (2002) (4)
- Microfilarial granuloma of the breast in a patient with tropical pulmonary eosinophilia. (1977) (4)
- Contrasting clinical disease in Plasmodium vivax and Plasmodium falciparum malaria, and the association of both with cytokines (1992) (4)
- Effectiveness of passive case detection for imported malaria in a hospital setting in Sri Lanka during the prevention of re-introduction phase of malaria. (2018) (4)
- Cloning and characterisation of a gene from Plasmodium vivax and P. knowlesi: homology with valine-tRNA synthetase. (1996) (4)
- Epidemiological profile of imported malaria cases in the prevention of reestablishment phase in Sri Lanka (2021) (4)
- Role of a dedicated support group in retaining Sri Lanka's malaria-free status (2021) (3)
- Transfusion-induced Plasmodium falciparum malaria in a beta thalassaemia patient during the prevention of re-establishment phase in Sri Lanka (2021) (3)
- Impact of the malaria comprehensive case management programme in Odisha, India (2022) (3)
- Malaria vaccine research - a game of chess. (1991) (3)
- Vivax series : The paroxysm of Plasmodium vivax malaria (2003) (3)
- Immune responses against sexual stages of Plasmodium vivax during human malarial infections in Sri Lanka. (1991) (3)
- Atypical presentations of malaria associated with chloroquine resistance. (1995) (2)
- Malaria policy advisory committee to the WHO: conclusions and recommendations of fifth biannual meeting (March 2014) (2014) (2)
- Cytoadherence and its association with clinical disease in Plasmodium falciparum infections in Sri Lanka (2010) (1)
- TNF and Other Cytokines in Malaria: Dual Role in Pathology and Protection (1992) (1)
- Thrombocytopenia in Malaria: A Red-Herring for Dengue, Delaying the Diagnosis of Imported Malaria (2021) (1)
- Plasmodium vivax malaria in Sri Lanka: transmission, disease and immunity. (1993) (1)
- Characterization of two Plasmodium vivax genes cloned by screening with transmission-blocking monoclonal antibodies (1997) (1)
- PERSPECTIVE MEASURING MALARIA (2006) (1)
- WHO comments on oral artemisinin monotherapy (2017) (0)
- inactivation ofmalarial gametocytes is dependent on thepresenceofwhitebloodcells andinvolves reactive nitrogen intermediates (1993) (0)
- Preventing the re-establishment of malaria in Sri Lanka amidst the COVID-19 pandemic (2020) (0)
- ABsTT.ucT. Descriptions and illustrations of the pupa and larva of Anophetes tCeZi%a) degans are presented for the first time. The bionomics and medical significance of this species are reviewed and updated. (1983) (0)
- The Financial Cost of Malaria Elimination in Sri Lanka Was Not More than that of Malaria Control (2019) (0)
- Technical and operational underpinnings of malaria elimination from Sri Lanka (2019) (0)
- recombinant protein containing a C-terminal fragment of the MSP-1 protein of an infectious Plasmodium to humans for the production of antimalarial vaccines (1996) (0)
- Mass drug administration should be implemented as a tool to accelerate elimination: against (2019) (0)
- Mathematical simulations of transmission blocking vaccine strategies for P. vivax malaria. (1994) (0)
- Nelson's personal experiences of surgery (2005) (0)
- MIM/TDR task force on malaria research capability strengthening in Africa. (2002) (0)
- Mass radical treatment of a group of foreign workers to mitigate the risk of re-establishment of malaria in Sri Lanka (2020) (0)
- Malaria elimination does not cost more than malaria control: Sri Lanka a case in point (2022) (0)
- Malaria Control, Elimination, and Prevention as Components of Health Security: A Review (2022) (0)
- Antibody responses toPlasmodium falciparum andP.vivax sporozoites inareaswithstable andunstable malaria (1990) (0)
- Severe and complicated malaria in two southern asian countries (Sri Lanka and Myanmar) (1998) (0)
- A comparative analysis of the outcome of malaria case surveillance strategies in Sri Lanka in the prevention of re‐establishment phase (2021) (0)
- High plasma TNF-α levels and TNF-α/IL-10 ratios are associated with TNF2 allele in severe P. falciparum malaria patients in Sri Lanka (P3023) (2013) (0)
- What it takes to sustain a malaria-free Sri Lanka (2015) (0)
- Demonstration ofAntigenic Polymorphism inPlasmodium vivax Malaria with a Panelof30Monoclonal Antibodies (1987) (0)
- The first introduced malaria case reported from Sri Lanka after elimination: implications for preventing the re-introduction of malaria in recently eliminated countries (2019) (0)
- Characterization of imported malaria, the largest threat to sustained malaria elimination from Sri Lanka (2015) (0)
- Transfusion-induced Plasmodium falciparum malaria in a beta thalassaemia patient during the prevention of re-establishment phase in Sri Lanka (2021) (0)
- Malaria elimination does not cost more than malaria control: Sri Lanka a case in point (2022) (0)
This paper list is powered by the following services:
Other Resources About Kamini Nirmala Mendis
What Schools Are Affiliated With Kamini Nirmala Mendis?
Kamini Nirmala Mendis is affiliated with the following schools:
